Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Credit agrmnt [a]
Appointed CFO
Quarterly results
Director departure
CC transcript
|
|
Anika Therapeutics, Inc. (ANIK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Nunes Anne (SVP, Chief Operations Officer) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 732 shares
@ $18.63, valued at
$13.6k
Exercised 2,491 restricted stock units
@ $0 |
|
| 08/11/2023 |
4
| Levitz Michael L (EVP, CFO, Treasurer) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,133 shares
@ $18.58, valued at
$21.1k
Exercised 3,859 restricted stock units
@ $0 |
|
| 06/16/2023 |
4
| VOGT SUSAN L N (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 6,500 shares
@ $0 |
|
| 06/16/2023 |
4
| Thompson Jeffery S (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 6,500 shares
@ $0 |
|
| 06/16/2023 |
4
| Richard Stephen (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 6,500 shares
@ $0 |
|
| 06/16/2023 |
4
| Larsen Glenn R. (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 6,500 shares
@ $0 |
|
| 06/16/2023 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 6,500 shares
@ $0 |
|
| 06/16/2023 |
4
| Fischetti Gary P (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 6,500 shares
@ $0 |
|
| 06/16/2023 |
4
| CONLEY SHERYL L (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 6,500 shares
@ $0 |
|
| 04/28/2023 |
4
| Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 10,900 shares
@ $26.34, valued at
$287.1k
Exercised 24,575 restricted stock units
@ $0 |
|
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/14/2023 |
4
| Levitz Michael L (EVP, CFO, Treasurer) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,609 shares
@ $26.1, valued at
$68.1k
Exercised 8,888 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| Colleran David (EVP, General Counsel, Corp Sec) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,250 shares
@ $26.1, valued at
$58.7k
Exercised 7,663 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 13,211 shares
@ $26.1, valued at
$344.8k
Exercised 30,060 restricted stock units
@ $0 |
|
| 03/10/2023 |
4
| Levitz Michael L (EVP, CFO, Treasurer) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,303 shares
@ $26.91, valued at
$35.1k
Granted 17,624 restricted stock units
@ $0
Granted 38,475 options to buy
@ $0
Exercised 4,439 restricted stock units
@ $0 |
|
| 03/10/2023 |
4
| Colleran David (EVP, General Counsel, Corp Sec) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,081 shares
@ $26.91, valued at
$29.1k
Granted 16,395 restricted stock units
@ $0
Granted 35,790 options to buy
@ $0
Exercised 3,683 restricted stock units
@ $0 |
|
| 03/10/2023 |
4
| Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,232 shares
@ $26.91, valued at
$113.9k
Granted 60,004 restricted stock units
@ $0
Granted 130,998 options to buy
@ $0
Exercised 14,419 restricted stock units
@ $0 |
|
| 03/07/2023 |
4
| Colleran David (EVP, General Counsel, Corp Sec) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 734 shares
@ $31.59, valued at
$23.2k
Exercised 2,500 restricted stock units
@ $0 |
|
| 08/11/2022 |
4
| Levitz Michael L (EVP, CFO, Treasurer) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Exercised 3,859 restricted stock units
@ $0 |
|
| 06/10/2022 |
4
| VOGT SUSAN L N (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 7,954 shares
@ $0 |
|
| 06/10/2022 |
4
| Richard Stephen (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 7,954 shares
@ $0 |
|
| 06/10/2022 |
4
| Larsen Glenn R. (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 7,954 shares
@ $0 |
|
| 06/10/2022 |
4
| HENNEMAN JOHN B III (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 7,954 shares
@ $0 |
|
| 06/10/2022 |
4
| CONLEY SHERYL L (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 7,954 shares
@ $0 |
|
| 06/10/2022 |
4
| Thompson Jeffery S (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 7,954 shares
@ $0 |
|
| 05/12/2022 |
4
| Colleran David (EVP, General Counsel, Corp Sec) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Bought 1,500 shares
@ $21.37, valued at
$32.1k
|
|
| 03/16/2022 |
4
| Colleran David (EVP, General Counsel, Corp Sec) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Bought 1,500 shares
@ $26.652, valued at
$40k
|
|
| 03/15/2022 |
4
| Colleran David (EVP, General Counsel, Corp Sec) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 22,988 restricted stock units
@ $0
Granted 35,864 options to buy
@ $0 |
|
| 03/15/2022 |
4
| Levitz Michael L (EVP, CFO, Treasurer) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 26,664 restricted stock units
@ $0
Granted 38,979 options to buy
@ $0 |
|
| 03/15/2022 |
4
| Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 90,179 restricted stock units
@ $0
Granted 208,821 options to buy
@ $0 |
|
| 03/15/2022 |
4
| Thompson Jeffery S (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Bought 2,000 shares
@ $24.659, valued at
$49.3k
|
|
| 03/14/2022 |
4
| Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Bought 4,287 shares
@ $25.359, valued at
$108.7k
Bought 3,813 shares
@ $25.814, valued at
$98.4k
|
|
| 03/14/2022 |
4
| Levitz Michael L (EVP, CFO, Treasurer) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Bought 4,000 shares
@ $24.619, valued at
$98.5k
|
|
|
|
|